Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025
Rhea-AI Summary
Assertio Holdings (NASDAQ: ASRT) has announced that its CEO, Brendan O'Grady, will participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025. The event will feature a fireside chat that will be webcast live at 11:20 a.m. ET. Interested participants can access the virtual presentation through registration on the provided Zoom link or by visiting the Events & Presentations section of Assertio's investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, ASRT declined 3.49%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the virtual Alliance Global Partners Healthcare Company Showcase, taking place Wednesday, May 21, 2025.
Mr. O’Grady’s fireside chat will be webcast live at 11:20 a.m. ET. To join the event, please register at https://us02web.zoom.us/webinar/register/WN_jB1HgKLvQFmUfC6VBT11mw#/registration, or visit the Events & Presentations page at the Company’s investor relations website, https://investor.assertiotx.com/.
About Assertio
Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. To learn more about Assertio, visit www.assertiotx.com.
Investor Contact
Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
mkreps@darrowir.com